Risks and Returns of Rocket Pharmaceuticals Inc (RCKT) Stock
Goldman raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “a Neutral”. The rating was released on April 02, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $45. The stock was initiated by Canaccord Genuity, who disclosed in […]
Rocket Pharmaceuticals Inc (RCKT) Stock is more thoughtful than you think
Goldman raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “a Neutral”. The rating was released on April 02, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $45. The stock was initiated by Canaccord Genuity, who disclosed in […]
Rocket Pharmaceuticals Inc (RCKT) Stock is more thoughtful than you think
Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]
A positive surprise is on the way: Rocket Pharmaceuticals Inc (RCKT) Stock
Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]
Investing in Rocket Pharmaceuticals Inc (RCKT) Stock: Methodology
Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]
Rocket Pharmaceuticals Inc (RCKT) Stock: Amazing technical data that you never knew existed
Cantor Fitzgerald raised the price target for the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) stock to “an Overweight”. The rating was released on October 24, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $53. The stock was initiated by BTIG Research, who disclosed […]
